Singapore to build up its vaccine manufacturing capacity to fight COVID-19 pandemic: PM Lee

Discovering, producing, and distributing a safe and effective vaccine is deemed vital to getting life back to normal.

Singapore is building up its vaccine manufacturing capacity to offer fill and finish contract manufacturing services to vaccine developers, Prime Minister Lee Hsien Loong stated during the Global Vaccine Summit 2020.

This move aims to help companies ramp up their production faster and assure them high standards of safety and quality in the manufacturing process, according to the Prime Minister.

Prime Minister Lee also said, “We (Singapore) are investing heavily in research and development on diagnostics, vaccines and therapeutics. Our researchers have developed a range of serological and nucleic acid-based diagnostic tests, which have been deployed to over 20 countries. They (researchers) are also developing therapeutic monoclonal antibodies as well as a vaccine, and have started clinical trials of various therapeutics.”

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia